Latest News Archive
Please select Category, Year, and then Month to display items
22 February 2018
Photo Thabo Kessah
Pakiso Mthembu will be representing South Africa in Mauritius and Algeria.
This year, the University of the Free State’s Qwaqwa Campus will unleash a running sensation that is equally comfortable on track, cross-country, and road running and is on a mission to conquer the world. His name is Pakiso Mthembu from Tweeling in the Eastern Free State. Pakiso has recently qualified for the Junior Men’s Southern Region cross-country championships that will be held in Mauritius on 24 February and in Algeria on 17 March 2018.
“I am glad that I managed to run my personal best time of 24:02 during the qualification trials held in Bloemfontein in January, which set me on the road to Mauritius and Algeria,” said Pakiso, a BEd FET first-year student.
His personal best in the 10 km road-running category and in the 5 000 m track are 30:55 and 14:29, respectively.
Praise for Soke
“It is only through dedication, hard work, and listening to my coach that I can achieve my dreams of representing South Africa at the International Association of Athletics Federations World Junior Championships (IAAF) to be held in Finland in July, and at the 2020 Tokyo Olympics. I have one of the best coaches in this part of the world and it gives me great pleasure to work with him, having grown up admiring him during his days,” he says in reference to Boy Soke, who identified his talent and recruited him to the Qwaqwa Campus.
Pakiso has already represented South Africa in Uganda.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”